D
Arcturus Therapeutics Holdings Inc. ARCT
$18.51 $1.035.89% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -60.16M -68.20M -80.94M -62.64M -71.96M
Total Depreciation and Amortization 3.31M 3.44M 3.54M 3.54M 3.46M
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 31.52M 35.00M 38.46M 38.46M 37.97M
Change in Net Operating Assets -39.61M -59.57M -20.81M -39.45M -38.19M
Cash from Operations -64.94M -89.33M -59.75M -60.09M -68.73M
Capital Expenditure -217.00K -545.00K -648.00K -1.52M -2.42M
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing -217.00K -545.00K -648.00K -1.52M -2.42M
Total Debt Issued 15.00M 15.00M -- 0.00 20.00M
Total Debt Repaid -15.00M -- -- -20.00M -20.00M
Issuance of Common Stock 1.30M 3.43M 5.42M 6.63M 7.77M
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing 1.30M 18.43M 5.42M -13.37M 7.77M
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -63.86M -71.45M -54.98M -74.99M -63.38M